GSK lifts profit and sales guidance after shingles vaccine boost
UK drugmaker beats forecasts and ‘expects good momentum in 2023’
Full Article
GSK lifts profit and sales guidance after shingles vaccine boost
FT.com
0 shares
1 views
You might like
Related news coverage
GSK lifts sales forecasts following ‘record’ success from shingles vaccine
British pharmaceutical giant GlaxoSmithKline (GSK) has raised its sales forecast for the full year, on the back of the success of..
City A.M.